Corrigendum: JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure (Circulation Journal (2025) 89 (1278-1444) DOI: 10.1253/circj.CJ-25-0002)

In accordance with the proposal for JCS/JHFS 2025 guideline on diagnosis and treatment of heart failure from Japanese Association on Sarcopenia and Frailty and Japan Heart Rhythm Society, the authors corrected the tables as shown below. The gradient of the LVEF border has been changed from vertical to diagonal, the authors have replaced the Figure 8. 1) Page 1355, Table 9 (Corrected) (Table presented) References 1218a. Satake S, Arai H. Questionnaire for medical checkup of old-old (QMCOO). Geriatr Gerontol Int 2020; 20: 991 – 992. 1218b. Ishizaki T, Masui Y, Nakagawa T, Yoshida Y, Ishioka YL, Hori N, et al. Construct validity of a new health assessment questionnaire for the national screening program of older adults in Japan: The SONIC Study. Int J Environ Res Public Health 2022; 19: 10330. 2) Page 1316, the right column, line 21–22 and Page 1317, Recommendation Table (Recommendations and Levels of Evidence for Implantable Cardioverter Defibrillator Use in Primary Prevention of Sudden Cardiac Death in Heart Failure Patients) Incorrect: For non-ischemic HF patients meeting the same criteria, a Class IIa recommendation is given. Correct: For non-ischemic HF patients meeting the same criteria, a Class I or IIa recommendation is given depending on the presence or absence of NSVT, respectively, according to JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias.^{687a,687b,687c,719} References 687a. Sasaki S, Noda T, Okumura K, Nitta T, Aizawa Y, Ohe T, et al. Effectiveness of implantable cardioverter defibrillator in patients with non-ischemic heart failure with systolic dysfunction: Subanalysis of the Nippon Storm Study. Circ J 2022; 87: 92 – 100. 687b. Aonuma K, Ando K, Kusano K, Asai T, Inoue K, Inamura Y, et al.; HINODE Investigators. Primary results from the Japanese Heart Failure and Sudden Cardiac Death Prevention Trial (HINODE). ESC Heart Fail 2022; 9: 1584 – 1596. 687c. Kondo Y, Noda T, Takanashi Y, Sasaki S, Sato Y, Nitta T, et al. Two-year outcomes of primary prophylactic use of defibrillators for ischemic and non-ischemic cardiomyopathy: Propensity score-matched analysis from the Nippon Storm Study. Circ J 2024; 88: 1107 – 1114. 719. Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, et al. JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias. Circ J 2021; 85: 1104 – 1244. (Table presented) 3) Page 1306, Figure 8 (Figure presented).